<<

MIMS Summary Table

DRUGS TO AVOID IN G6PD DEFICIENCY

DEFINITE RISK OF HAEMOLYSIS POSSIBLE RISK OF HAEMOLYSIS

Pharmacological Drugs* Pharmacological Drugs* Class Class • ß-Naphthol • Acetylsalicylic acid • () • G6PD Deficiency (Acetaminophen) - - (Aminopyrine) • Quinolones • Dipyrone - () - - - (Antipyrine) - - Co-trimoxazole Antibiotics • ( + • ) • Sulfonamides - - Sulfacytine - - Sulfaguanidine - - - Sulfamethoxazole - Sulfamethoxypyridazole - - - Antidiabetics • (Salazosulfapyridine) - Sulfisoxazole (BAL) () • Antazoline (Antistine) • Antimalarials • • Tripelennamine • • Pentaquine Antihypertensives • Antimethemo- • Antimalarials • & derivatives globinaemic Agents • • Para-aminosalicylic acid • • Sulfones - Antimycobacterials • (Sulfoxone) - Glucosulfone Antiparkinsonism Agents • - Thiazosulfone (Benzhexol) Antineoplastic Adjuncts • Doxorubicin Cardiovascular Drugs • (L-dopa) • Rasburicase • Procainamide • Quinidine Genitourinary Analgesics • Diagnostic Agent • blue (Pyridium) for Cancer Detection

Others • Acetylphenylhydrazine Gout Preparations • Colchicine • • Probenecid Hormonal Contraceptives • Mestranol Nitrates • Isobutyl Vitamin K Substance • Menadiol Na • Menadione • Menadione Na bisulfite • Phytomenadione Vitamins • Ascorbic acid (Vit C) (rare) Others • Arsine • Berberine (in Coptis chinensis) • Fava beans • Naphthalene (in mothballs) • Para-aminobenzoic acid *Nomenclature based on INN (International non-proprietary name) Refer to www.g6pd.org for further information. Please refer to the Contents page for more Summary Tables.

ver01032006 Copyright © 2006 MIMS